
Funding drought could stall future cancer breakthroughs, experts warn
Cancer science has seen notable gains (including FDA approvals and falling mortality) but the AACR warns the field is at an inflection point due to funding cuts and declines in NIH awards, with political proposals risking further delays—posing a threat to AI-driven tools, new therapies, and the pace of progress in cancer care.













